N/A N=10 Improving Holding Function of the Hemiplegic Hand
Stroke
Primary: Geometric Ratios of Log-transformed Transit Time — 1.19; 1.07; 0.79; 0.72 dimensionless ratio — p=.059
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=72 Proof of Concept Anti-ageing Clinical Study in Healthy Subjects
Skin Aging
Primary: Change From Baseline in Ra (a dermaTOP Parameter), of Test Product Treated Versus (vs.) Untreated Side at Day 29 — -1.90; -0.12 Micro meter (µm) — p=0.0638
N/A N=470 Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure
Weaning Failure
Primary: Number of Patients With Extubation Failure — 58; 24 Participants
N/A N=607 A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Migraine
Primary: Pain Freedom at 2 Hours — 66; 51 Participants
Phase 3 N=606 Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Hemorrhagic Fever, Ebola
Primary: Survival at Day 14 After Start of Intervention — 58; 260 Participants
N/A N=54 Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions
Type 2 Diabetes
Primary: HbA1c After Intervention — 6.8; 6.4 percentage
N/A N=22 Effects of Animal-assisted Therapy on Brain-injured Patients
Impaired Social Functioning
Primary: Social Functioning: Total Social Behavior — 29.22; 8.68 percentage of shown behavior
Phase 4 N=48 Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Correlation of Plasma Levels of EPA and DHA With HbA1c Reduction — -0.414; 0.067; -0.319; 0.093 pearson's correlation coefficient
Phase 2 N=16 A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Anaphylaxis · Hypotension · Bronchospasm
Primary: Reduction in the Number and Timing of Anaphylactic Events in Subjects With a History of Frequent Idiopathic Anaphylaxis. — 32; 6 percentage of change of events
N/A N=18 Yoga as Self-Care for Arthritis in Minority Communities
Rheumatoid Arthritis · Arthritis
Primary: Self-Efficacy Exercise — 6.1 units on a scale
N/A N=37 Wellness Programs for Brain-Injured Individuals
Depression · Anxiety · Stroke
Primary: Depression Score Change on Geriatric Depression Scale — -.29; -1.46 units on a scale
N/A N=38 Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
Posterior Capsule Opacification · Retinal Degeneration · Retinal Detachment
Primary: Changes of Foveal and Pericentral Pigment Optical Density (Log Unit) From Baseline at 2 Months — 0.55; 0.52; 0.51; 0.5 log unit — p=<0.01
N/A N=920 Northwestern University and Access Community Health Network Medication Education Study
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
N/A N=15,724 Intensive Monitoring of Renal Function
Intensive Monitoring of Renal Function · Acute Kidney Injury
Primary: Detection of Acute Kidney Injury (AKI) — 1.22; 1.22; 1.11; 1.11 Odds Ratio
Phase 3 N=19 A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures
Epilepsy · Partial-onset Seizures
Primary: Number of Subjects With at Least One Incidence of Treatment-Emergent Adverse Events (TEAEs) During the Study — 19 Participants